Gene editing techniques may one day allow for the removal of the extra chromosome that causes Down syndrome, early ...
The consensus price target for CRISPR Therapeutics AG (NASDAQ:CRSP) has been adjusted from $72.75 to $65, reflecting changes in financial performance and industry developments. Despite a quarterly ...
Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro ...